While waiting for new quarter news … if you haven’t tried the products from the company your invested in / thinking of investing in … I highly recommend trying the products :~)
I was a share holder, intrigued by the science and data surrounding escozine and the polarization technology … as soon as the imunapen became available for purchase I was happy for the chance to try it - glad I did too!
Let’s all hope 2022 all the leading up to where we are now hard work & years of research culminates to strengthened international relationships coupled with brokered deals, contracts, sales both retail & wholesale alike of AELIA, MedolifeRx & escozine globally!!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.